Cargando…
Potentials of incretin‐based therapies in dementia and stroke in type 2 diabetes mellitus
Patients with type 2 diabetes mellitus are at risk for accelerated cognitive decline and dementia. Furthermore, their risk of stroke is increased and their outcome after stroke is worse than in those without diabetes. Incretin‐based therapies are a class of antidiabetic agents that are of interest i...
Autores principales: | Groeneveld, Onno N, Kappelle, L Jaap, Biessels, Geert Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718099/ https://www.ncbi.nlm.nih.gov/pubmed/26816596 http://dx.doi.org/10.1111/jdi.12420 |
Ejemplares similares
-
Disruption of the Cerebral White Matter Network Is Related to Slowing of Information Processing Speed in Patients With Type 2 Diabetes
por: Reijmer, Yael D., et al.
Publicado: (2013) -
Perfusion CT in suspected ischaemic stroke: red flags that should have been blue
por: Huisman, Mark H. B., et al.
Publicado: (2010) -
Renoprotective Effects of Incretin-Based Therapy in Diabetes Mellitus
por: Yaribeygi, Habib, et al.
Publicado: (2021) -
Microstructural White Matter Abnormalities and Cognitive Functioning in Type 2 Diabetes: A diffusion tensor imaging study
por: Reijmer, Yael D., et al.
Publicado: (2013) -
Depressive symptoms and quality of life after screening for cognitive impairment in patients with type 2 diabetes: observations from the Cog-ID cohort study
por: Janssen, Jolien, et al.
Publicado: (2019)